Comparative CNS Pharmacology of the Bruton’s Tyrosine Kinase (BTK) Inhibitor Tolebrutinib Versus Other BTK Inhibitor Candidates for Treating Multiple Sclerosis

Related articles

1. Actions of Midostaurin as Tyrosine Kinase and Cation Channel Inhibitor in Diffuse Intrinsic Pontine Glioma Cell Lines

   This article has 8 authors:

   1. Marina Antonacci
   2. Annamaria Di Turi
   3. Morena Miciaccia
   4. Michele Denora
   5. Fatima Maqoud
   6. Maria Grazia Perrone
   7. Antonio Scilimati
   8. Domenico Tricarico

2. Determination of the Structural and Pharmacokinetic Basis for Dihydropyridine Calcium Channel Blocker Activity: An In-Silico Investigation Targeting the L-Type Calcium Channel (CaV1.2)

   This article has 6 authors:

   1. Roy Tatenda Bisenti
   2. Tinashe Sibamba
   3. Glee C. Muriravanhu
   4. Amos Misi
   5. Albert Wakandigara
   6. Paul Mushonga

3. Advances in Small-Molecule Inhibitors of MKK4 and MKK7: From Structural Biology to Therapeutic Applications

   This article has 7 authors:

   1. Min Zhao
   2. Baojian Li
   3. Ying Gao
   4. Yan Liang
   5. Nanqi Shao
   6. Xinbo Shi
   7. Jie Li